In fact, a cross-sectional study in a Spanish population demonstrated a positive and independent association between serum sclerostin levels and atherosclerosis in T2DM patients showing high concentrations of sclerostin associated with abnormal intima-media thickness (IMT), carotid plaques, and aortic calcifications in T2DM patients [60]. This evidence concerns the gene SOST and atherosclerosis.